BioWorld

July 29, 2003

View Archived Issues

Clusterin Protein May Improve Important, Lifesaving Early Colon Cancer Call Over Colonoscopy

Read More

OxiGene Gets Orphan Status For CA4P; Stock Soars 50 Percent

Read More

Other News To Note

Read More

MGI Offering Could Gross $128M Following FDA Approval Of Aloxi

Capitalizing on a stock surge prompted by Friday's approval of a partnered cancer drug, MGI Pharma Inc. on Monday reported plans to sell 4 million shares. (BioWorld Today) Read More

ISTA Gets Approvable Letter On Product To Treat Glaucoma

Read More